FREM1 and breast carcinoma: Thus, we used the TIMER database to evaluate the correlation between FREM1 mRNA expression and six different infiltrating immune cell types (B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils and dendritic cells) in different subtypes of breast cancer.